Annals of Surgery · 2011 · 123 citations · 28 references
Veterinary MedicineCell BiologyPathologyInflammationTissue DifferentiationWound HealingFibrosisSkin RegenerationTissue RepairWound ContractionWound Healing PhysiologyWound Healing ResponseCutaneous Wound HealingDiabetic Wound HealingDiabetic Wound PathophysiologyDiabetic Wound RepairFibroblast ActivationGrowth FactorsProinflammatory MediatorsSkin Wound Contraction
OBJECTIVE: To identify the in vitro characteristics and functional properties of fibrocytes and investigate the in vivo mechanism of action of fibrocytes injection in accelerating the cutaneous healing process in diabetic mice. BACKGROUND: Fibrocytes are hematopoietic derived stem cells that may have a role in tissue repair, perhaps as the precursors of fibroblast- or myofibroblast-like cells. METHODS: In vitro, the time-dependent phenotypic expression of peripheral blood (PB) fibrocytes was stained with anti-CD11b, anti-CD45, anti-Col-I, and anti-α-SMA antibodies. The functional properties of fibrocytes and dermal fibroblasts were tested by using reverse-transcriptase polymerase chain reaction. In vivo, full thickness wounds in diabetic mice were treated either with fibrocytes, dermal fibroblasts, or phosphate buffered saline (PBS) through tail vein injection. Wound healing kinetics, including wound contraction, re-epithelialization, and microscopic metrics such as cell proliferation, angiogenesis, and granulation growth were investigated. Expression of proinflammatory factors, profibrotic factors, growth factors, and extracellular matrix components were measured in wound tissues. RESULTS: Fibrocytes gradually lose their hematopoietic cell markers and increase mesenchymal cell markers during differentiation in vitro. Fibrocytes stimulate wound healing by dermal cell proliferation, keratinocyte proliferation with re-epithelialization, and angiogenesis compared with dermal fibroblast and PBS treated wounds. Expression of angiogenesis markers (VEGF and b-FGF), growth factors (TGF-β, PDGF-A, and FGF-7), chemokines (MCP-1 and MIP-1α), and extracellular matrix (collagen-I and α-SMA) were upregulated in fibrocyte-treated wounds. CONCLUSION: Peripheral blood fibrocytes can accelerate wound healing by stimulating cell proliferation, re-epithelialization, and angiogenesis in a diabetic mice experimental model. The application of fibrocytes may represent a potential clinical solution for the treatment of chronic wounds across all fields of surgery.
28
Circulating Fibrocytes Define a New Leukocyte Subpopulation That Mediates Tissue Repair
Richard Bucala, Lori Spiegel, Jason Chesney et al. · Molecular Medicine · 1994 · 1.3K citations · Full text
Peripheral Blood Fibrocytes: Differentiation Pathway and Migration to Wound Sites
Riichiro Abe, Seamas C. Donnelly, Tina Peng et al. · The Journal of Immunology · 2001 · 959 citations · Full text
Endothelial Progenitor Cell Dysfunction
Cindy J.M. Loomans, Eelco J.P. de Koning, Frank J. T. Staal et al. · Diabetes · 2004 · 837 citations